Search Options Stock News and Analysis from Schaeffer's

Novo Nordisk Stock Suffers After C-Suite Shakeup

https://www.schaeffersresearch.com/content/news/2025/05/16/novo-nordisk-stock-suffers-after-c-suite-shakeup

5/16/2025 9:59 AM

Novo Nordisk A/S (NYSE:NVO) is down 3.9% to trade at $63.60 this morning, after a C-suite shakeup. CEO Lars Fruergaard Jørgensen will be stepping down, citing market challenges and increased competiti...

Eli Lilly Stock Moves Lower on Rare Double Downgrade

https://www.schaeffersresearch.com/content/news/2025/04/28/eli-lilly-stock-moves-lower-on-rare-double-downgrade

4/28/2025 11:19 AM

Eli Lilly And Co (NYSE:LLY) stock is 1.6% lower to trade at $870.31 at last check, after a rare double downgrade from HSBC to "reduce" from "buy," and a price-target cut to $700 from $1,150. The analy...

Eli Lilly Stock Surges on Weight-Loss Drug Trial Success

https://www.schaeffersresearch.com/content/news/2025/04/17/eli-lilly-stock-surges-on-weight-loss-drug-trial-success

4/17/2025 11:10 AM

Eli Lilly & Co (NYSE:LLY) stock is headed for its best day since August 2023, last seen up 13.4% at $838.48 at last check, after the pharmaceutical giant reported positive results for a phase 3 tria...

2 Sleep Apnea Stocks in Focus Today

https://www.schaeffersresearch.com/content/news/2024/12/23/2-sleep-apnea-stocks-in-focus-today

12/23/2024 10:51 AM

Eli Lilly and Co (NYSE:LLY) is in focus today, after the U.S. Food & Drug Administration (FDA) approved its weight-loss drug, Zepbound, to treat obstructive sleep apnea in adults with obesity -- the f...

Novo Nordisk Stock Eyes Worst Day, Week on Record

https://www.schaeffersresearch.com/content/news/2024/12/20/novo-nordisk-stock-eyes-worst-day-week-on-record

12/20/2024 10:29 AM

Novo Nordisk A/S (NYSE:NVO) stock is down 18.9% to trade at $82.25 at last check, after the pharmaceutical company's weight loss drug CagriSema missed expectations of a late-stage study. The populariz...

PEOPLE ALSO SEARCH FOR